The present invention provides methods for ameliorating, overcoming, or
inhibiting insulin resistance in a subject, comprising administering to
the subject an effective amount of a compound selected from the group
consisting of LR-90 and LR-102, or a pharmaceutically acceptable salt or
derivative thereof. Methods of treating type 2 diabetes and diabetic
nephropathy, or preventing or slowing their development are also
encompassed by the invention.